PNT
POINT BIOPHARMA GLOBAL INC (PNT)
$6.72
Market is closedMarket is closed – opens on 8 PM, 06 Dec 2022
– opens on 8 PM, 06 Dec 2022
Key Stats
$6.485
Day's Range
$6.85
$4.25
52-Week Range
$10.98
| Returns | |
| 1 month return | 20.66% |
| 3 month return | 8.07% |
| 1 year return | 8.04% |
| 5 year return | 23.64% |
Company Information
POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), and industry-leading manufacturing capabilities and supply chain to revolutionize theragnostic drug development and radioligand commercialization.
| Organization | POINT BIOPHARMA GLOBAL INC |
| Employees | 72 |
| CEO | Mr. Allan Charles Silber |
| Industry | Healthcare |
Analyst Recommendation
based on 13 analysts ratings
Buy
92%
Buy
7%
Hold
0%
Sell
Based on 13 Wall street analysts offering stock ratings for POINT BIOPHARMA GLOBAL INC(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 156.25%Current
$6.72
Target
$17.22
Recommendation Trend
Based on 13 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 12 | 9 | 7 |
| Hold | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Highlights
| Market Capitalization | 713.1M |
| Book Value | $2.97 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | -0.69 |
| Wall Street Target Price | 17.22 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 63.29 |
| Price/Book (mrq) | 2.28 |
| Enterprise Value | 706.1M |
| Enterprise Value/Revenue | 0.0 |
| Enterprise Value/Ebitda | -8.83 |
Technicals
| Beta | 0.28 |
| 50 Day MA | 7.76 |
| 200 Day MA | 7.76 |
Institutional Holdings
BlackRock Inc
5.82%
Partner Fund Management LP
4.27%
Vanguard Group Inc
3.67%
Point72 Asset Management, L.P.
3.5%
Great Point Partners LLC
3.37%
Bvf Inc
3.19%
Discover more
Frequently Asked Questions
What is POINT BIOPHARMA GLOBAL INC share price today?
Can Indians buy POINT BIOPHARMA GLOBAL INC shares?
How can I buy POINT BIOPHARMA GLOBAL INC shares from India?
Can Fractional shares of POINT BIOPHARMA GLOBAL INC be purchased?
What are the documents required to start investing in POINT BIOPHARMA GLOBAL INC stocks?
What are today’s High and Low prices of POINT BIOPHARMA GLOBAL INC?
What are today’s traded volumes of POINT BIOPHARMA GLOBAL INC?
What is today’s market capitalisation of POINT BIOPHARMA GLOBAL INC?
What is the 52 Week High and Low Range of POINT BIOPHARMA GLOBAL INC?
How much percentage POINT BIOPHARMA GLOBAL INC is down from its 52 Week High?
How much percentage POINT BIOPHARMA GLOBAL INC is up from its 52 Week low?
What are the historical returns of POINT BIOPHARMA GLOBAL INC?
Who is the Chief Executive Officer (CEO) of POINT BIOPHARMA GLOBAL INC?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*